TCT 991: Hemodynamic and Echocardiographic Effects of TTVR in Patients with Severe Tricuspid Regurgitation

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Edwards Lifesciences; Medtronic; Boston Scientific Corporation</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Edwards Lifesciences</li></ul>